-
公开(公告)号:DK1720999T3
公开(公告)日:2009-05-04
申请号:DK05713781
申请日:2005-02-18
Applicant: BAXTER INT , BAXTER HEALTHCARE SA
Inventor: MARTIS LEO , PATEL MEHUL , GIERTYCH JOSEPH A , MONGOVEN JAMES W , KUNZLER JACQUELINE A , OWEN WILLIAM F JR
IPC: C12Q1/37 , C12Q1/04 , C12Q1/26 , G01N33/569
Abstract: Methods and compositions for detection of microbial contaminants in peritoneal dialysis solutions are provided. A novel cause of aseptic peritonitis is provided—aseptic peritonitis associated with gram positive microbial contamination of a dialysis solution. Peptidoglycan is a major component of a gram positive bacterial cell wall and thus can serve as a marker for gram positive bacteria. In this regard, testing for peptidoglycans can be utilized to effectively prevent peritonitis in patients that use the peritoneal dialysis solutions, such as peritoneal dialysis solutions that contain a glucose polymer including an icodextrin and the like.
-
公开(公告)号:AU2003299683B2
公开(公告)日:2008-10-02
申请号:AU2003299683
申请日:2003-12-18
Applicant: BAXTER HEALTHCARE SA , BAXTER INT
Inventor: CHOO CAROLYN , MARTIS LEO , ZIESKE PAUL
IPC: A61K31/718 , A61K31/724 , A61M1/28
Abstract: Icodextrin-based solutions and methods of making same that can be used during medical therapy, such as dialysis therapy are provided. The icodextrin-based solution at least includes a first solution containing icodextrin at a pH ranging from about 1.5 to about 5.0 and a buffer solution at a pH ranging from about 7.0 to about 12.0 that are so constructed and arranged allowing the icodextrin-based solution to be mixed prior to infusion into a patient. The icodextrin-based solutions of the present invention can be made at physiologic pH and with minimal glucose degradation products.
-
公开(公告)号:DE60227189D1
公开(公告)日:2008-07-31
申请号:DE60227189
申请日:2002-10-01
Applicant: BAXTER INT
Inventor: KAROOR SUJATHA , DONOVAN BRIAN , HAI TON THAT , KATADA MARI , LU LUIS , MARTIS LEO , MORTI STAVROULA , MUJAIS SALIM , SANDERS PAUL , SOLTYS PAUL , TANDON RAHUL
IPC: A61M1/16 , A61M1/36 , A61M1/28 , A61M1/34 , B01D15/00 , B01J20/02 , B01J20/06 , B01J20/20 , B01J20/22 , B01J39/10 , B01J41/10
Abstract: The invention provides a device (32) for removing uremic toxins in a dialysis procedure comprising a body having an inlet (42) and an outlet (44) and defining an interior. The interior includes a layer comprising urease, a layer comprising zirconium oxide, a layer comprising zirconium phosphate, and a layer comprising carbon. The device is constructed and arranged so that a fluid entering the device contacts the zirconium phosphate layer before contacting the urease layer and before contacting the zirconium oxide layer.
-
公开(公告)号:DE60030682T2
公开(公告)日:2007-09-06
申请号:DE60030682
申请日:2000-07-27
Applicant: BAXTER INT
Inventor: DUPONCHELLE ANNICK , FAICT DIRK , BALTEAU PATRICK , HARTMAN JEAN-PIERRE , MARTIS LEO , PELUSO FRANCESCO
-
公开(公告)号:DE69332106T3
公开(公告)日:2007-03-01
申请号:DE69332106
申请日:1993-12-10
Applicant: BAXTER INT
Inventor: MARTIS LEO , FAICT DIRK , BURKE RON
IPC: A61K9/08 , A61K38/00 , A61K31/70 , A61K33/00 , A61K38/01 , A61K38/02 , A61K47/26 , A61K47/42 , A61M1/14 , A61M1/18 , A61M1/28 , A61P7/08
Abstract: The solution contains as osmotic agents both dectrose and polypeptides. The polypeptides are synthetic and are 4 to 10 amino acids long.
-
公开(公告)号:AU2003249296A1
公开(公告)日:2004-02-09
申请号:AU2003249296
申请日:2003-07-16
Applicant: BAXTER INT
Inventor: CHILDERS ROBERT W , BROWN DAVID S , WARIAR RAMESH , KAROOR SUJATHA , DIN SHAHID , MARTIS LEO , BUCHMANN CODY , SOLTYS PAUL
Abstract: A system for dialysis is disclosed. An example peritoneal dialysis system includes a peritoneal dialysis machine including a pumping mechanism, and a sensor configured to measure a property of peritoneal dialysis fluid. The peritoneal dialysis system also includes a disposable cassette operable with the peritoneal dialysis machine. The disposable cassette includes a fluid source inlet for accepting fluid from a fluid source and a fluid flow path in fluid communication with the fluid source inlet. The fluid flow path includes a pump chamber operable with the pumping mechanism to pump fluid through the fluid flow path. The disposable cassette also includes a concentrate inlet for fluidly communicating concentrate to the fluid flow path, and a sensor chamber located along the fluid flow path and operable with the sensor. The sensor is configured to provide feedback to the peritoneal dialysis machine for mixing the concentrate for forming peritoneal dialysis fluid.
-
公开(公告)号:AT246508T
公开(公告)日:2003-08-15
申请号:AT95908701
申请日:1995-01-23
Applicant: BAXTER INT
Inventor: MARTIS LEO , BURKE RON , SHOCKLEY TY , HENDERSON LEE W , FALLER BERNARDETTE
IPC: A61M1/14 , A61K31/715 , A61K33/14 , A61M1/28
Abstract: The method relates to providing an osmotic agent for a peritoneal dialysis solution containing sodium chloride and optionally lactate, bicarbonate, calcium and magnesium ions. The osmotic agent added comprises a first composition with a weight average molecular weight of ≥ 10,000 daltons and 0.25 to 2.0 (% w/v) of a second composition with a weight average molecular weight of ≤ 300 daltons.
-
公开(公告)号:AT222766T
公开(公告)日:2002-09-15
申请号:AT95921482
申请日:1995-05-25
Applicant: BAXTER INT
Inventor: MARTIS LEO , HENDERSON LEE W
IPC: A61K9/08 , A61K31/19 , A61K31/194 , A61K31/70 , A61K31/7004 , A61K33/00 , A61K33/10 , A61K33/14 , A61M1/28 , A61P7/08 , A61P13/12 , A61M1/16
Abstract: A peritoneal dialysis solution that is biochemically balanced to correct metabolic acidosis associated with chronic renal failure in a more physiological manner. The peritoneal dialysis solution has a physiological pH, e.g. pH of 70 to 74 and contains bicarbonate at a concentration that is found in normal blood. Additionally, the solution contains carbon dioxide at a partial pressure that is similar to partial pressure of carbon dioxide found in normal blood. The peritoneal dialysis solution also contains a weak acid with a pKa of less than 5.0.
-
公开(公告)号:AT221380T
公开(公告)日:2002-08-15
申请号:AT98200026
申请日:1995-01-23
Applicant: BAXTER INT
Inventor: MARTIS LEO , SHOCKLEY TY , BURKE RON , HENDERSON LEE W , FALLER BERNARDETTE
IPC: A61M1/14 , A61K31/715 , A61K33/14 , A61M1/28 , A61K33/10 , A61K31/415 , A61K31/405 , A61K31/40 , A61K31/195
Abstract: The method relates to providing an osmotic agent for a peritoneal dialysis solution containing sodium chloride and optionally lactate, bicarbonate, calcium and magnesium ions. The osmotic agent added comprises a first composition with a weight average molecular weight of ≥ 10,000 daltons and 0.25 to 2.0 (% w/v) of a second composition with a weight average molecular weight of ≤ 300 daltons.
-
公开(公告)号:AU6384200A
公开(公告)日:2001-04-10
申请号:AU6384200
申请日:2000-07-27
Applicant: BAXTER INT
Inventor: DUPONCHELLE ANNICK , FAICT DIRK , BALTEAU PATRICK , HARTMAN JEAN-PIERRE , MARTIS LEO , PELUSO FRANCESCO
-
-
-
-
-
-
-
-
-